Filing Details

Accession Number:
0001752836-20-000024
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-02-11 16:08:07
Reporting Period:
2020-02-07
Accepted Time:
2020-02-11 16:08:07
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1752836 Covetrus Inc. CVET Retail-Drug Stores And Proprietary Stores (5912) 831448706
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1765583 Jr. C. Anthony Providenti 7 Custom House Street
Portland ME 04101
See Remarks No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2020-02-07 333 $13.00 0 No 4 S Indirect By 401(k) Plan
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect By 401(k) Plan
Footnotes
  1. The Reporting Person is a former employee of Henry Schein, Inc. As a result of Henry Schein, Inc.'s spinoff transaction resulting in Covetrus, Inc. being an independent public company, participants in the Henry Schein 401(k) Savings Plan (the "Henry Schein Plan") who held units in the Henry Schein stock fund as of February 7, 2019 (closing date of the spinoff transaction) were credited with 0.4 of a unit in the Covetrus stock fund for every one unit held of the Henry Schein stock fund. On February 7, 2020, the Covetrus stock fund was removed as an investment option offered through the Henry Schein Plan. Any amounts invested in the Covetrus stock fund as of February 7, 2020 were automatically sold with no investment decision exercised by the holder. This Form 4 reports that automatic sale.
  2. The number of shares sold reflects the Reporting Person's interest in equivalent shares of Covetrus common stock held by the unitized stock fund in the Henry Schein Plan. The unitized stock fund consists of Covetrus common stock and cash or cash equivalents. The number of shares attributed to the Reporting Person as a participant in the Henry Schein Plan and expressed as equivalent shares has been calculated based on the closing price of Covetrus common stock on the date of the reported transaction.